JP2000510151A - トランスフェクション剤としてのポリカチオン性ステロール誘導体 - Google Patents
トランスフェクション剤としてのポリカチオン性ステロール誘導体Info
- Publication number
- JP2000510151A JP2000510151A JP09541840A JP54184097A JP2000510151A JP 2000510151 A JP2000510151 A JP 2000510151A JP 09541840 A JP09541840 A JP 09541840A JP 54184097 A JP54184097 A JP 54184097A JP 2000510151 A JP2000510151 A JP 2000510151A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- group
- prepared
- cationic liposome
- cholesterol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/05—Animals modified by non-integrating nucleic acids, e.g. antisense, RNAi, morpholino, episomal vector, for non-therapeutic purpose
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0393—Animal model comprising a reporter system for screening tests
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.カチオン性脂質として作用し得る化合物であって、該化合物は、頭部基が結 合しているコレステロール基を含み; ここで、該頭部基が、DC-Cholの頭部基よりも正電荷を有し; ここで、該頭部基が、ポリアミン基であり;そして ここで、該ポリアミン基の2つ以上のアミン基が、天然に存在するポリアミン 化合物のアミン基を分離する、天然には見出されない1つ以上の基によって分離 され; しかしここで、該化合物は、N,N-ジイソプロピルエチルアミンの存在下で、CH2 Cl2中でスペルミジンとコレステロールクロロホルメートとを反応させることに よっては合成されない、化合物。 2.前記コレステロール基が、コレステロールである、請求項1に記載の化合物 。 3.前記コレステロール基が、カルバモイル結合を介して、前記頭部基に結合し ている、請求項1または2に記載の化合物。 4.ヌクレオチド配列との混合物であるか、またはヌクレオチド配列と会合して いる、請求項1〜3のいずれか1項に記載の化合物。 5.請求項1〜4のいずれか1項に記載の化合物を調製する方法であって、コレ ステロール基を頭部基と反応させる工程を包含する、方法。 6.前記方法が、少なくとも1つのアザ-ウィッティヒ法を利用する工程を包含 する、請求項5に記載の方法。 7.治療における使用のための、請求項1〜4のいずれか1項に記載の化合物、 あるいは請求項5または6に記載の方法により調製される化合物。 8.遺伝的障害または状態または疾患の処置用の医薬品の製造における、請求項 1〜4のいずれか1項に記載の化合物あるいは請求項5または6に記載の方法に より調製される化合物の使用。 9.請求項1〜4のいずれか1項に記載の化合物あるいは請求項5または6に記 載の方法により調製される化合物から形成される、カチオン性リポソーム。 10.請求項1〜4のいずれか1項に記載の化合物あるいは請求項5または6に 記載の方法により調製される化合物からカチオン性リポソームを形成する工程を 包含する、カチオン性リポソームを調製する方法。 11.治療における使用のための、請求項9に記載のカチオン性リポソームまた は請求項10に記載の方法により調製されるカチオン性リポソーム。 12.遺伝的障害または状態または疾患の処置用の医薬品の製造における、請求 項9に記載のカチオン性リポソームまたは請求項10に記載の方法により調製さ れるカチオン性リポソームの使用。 13.ヌクレオチド配列と、以下の1つ以上との組合せ:請求項1〜4のいずれ か1項に記載の化合物、請求項5または6に記載の方法により調製される化合物 、請求項9に記載のカチオン性リポソーム、あるいは請求項10の方法により調 製されるカチオン性リポソーム。 14.治療における使用のための、請求項13に記載の組合せ。 15.遺伝的障害または状態または疾患の処置用の医薬品の製造における、請求 項14に記載の組合せの使用。 16.薬剤と混合された、および必要に応じて、薬学的に受容可能な希釈剤、キ ャリア、または賦形剤と混合された、請求項1〜4のいずれか1項に記載の化合 物あるいは請求項5または6に記載の方法により調製される化合物を含む、薬学 的組成物。 17.薬剤と混合された、および必要に応じて、薬学的に受容可能な希釈剤、キ ャリア、または賦形剤と混合された、請求項9に記載のカチオン性リポソーム、 または請求項10の方法により調製されるカチオン性リポソームを含む、薬学的 組成物。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9610944.2 | 1996-05-24 | ||
GBGB9610944.2A GB9610944D0 (en) | 1996-05-24 | 1996-05-24 | A compound |
GBGB9705498.5A GB9705498D0 (en) | 1996-05-24 | 1997-03-17 | A compound |
GB9705498.5 | 1997-03-17 | ||
PCT/GB1997/001426 WO1997045442A1 (en) | 1996-05-24 | 1997-05-23 | Polycationic sterol derivatives as transfection agents |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2000510151A true JP2000510151A (ja) | 2000-08-08 |
JP4340330B2 JP4340330B2 (ja) | 2009-10-07 |
Family
ID=26309393
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP54184097A Expired - Fee Related JP4340330B2 (ja) | 1996-05-24 | 1997-05-23 | トランスフェクション剤としてのポリカチオン性ステロール誘導体 |
Country Status (6)
Country | Link |
---|---|
US (3) | US6756054B1 (ja) |
EP (1) | EP0918790B1 (ja) |
JP (1) | JP4340330B2 (ja) |
AU (1) | AU2911197A (ja) |
DE (1) | DE69727384T2 (ja) |
WO (1) | WO1997045442A1 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008509205A (ja) * | 2004-08-13 | 2008-03-27 | アイシー・ベック・リミテッド | ポリマー修飾siRNAリポソームを含むベクター |
JP2008520610A (ja) * | 2004-11-19 | 2008-06-19 | グラクソ グループ リミテッド | トランスフェクション剤としてのテトラアルキレンペンタミンのアミドおよびペプチド誘導体 |
JP2015530382A (ja) * | 2012-08-28 | 2015-10-15 | メディカル リサーチ カウンシル | ナノ粒子製剤 |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5948767A (en) * | 1994-12-09 | 1999-09-07 | Genzyme Corporation | Cationic amphiphile/DNA complexes |
US5939401A (en) * | 1994-12-09 | 1999-08-17 | Genzyme Corporation | Cationic amphiphile compositions for intracellular delivery of therapeutic molecules |
US6383814B1 (en) | 1994-12-09 | 2002-05-07 | Genzyme Corporation | Cationic amphiphiles for intracellular delivery of therapeutic molecules |
US6331524B1 (en) | 1994-12-09 | 2001-12-18 | Genzyme Corporation | Organ-specific targeting of cationic amphiphile / DNA complexes for gene therapy |
US6197332B1 (en) | 1997-08-13 | 2001-03-06 | Chiron Corporation | Lipid-conjugated polyamide compounds and related compositions and methods thereof |
SE513149C2 (sv) * | 1997-12-05 | 2000-07-17 | Katarina Edwards | Läkemedelsdistributionssystem med tvåstegsmålsökning, till specifika celler eller vävnad och till dess cellkärna |
GB9808268D0 (en) * | 1998-04-17 | 1998-06-17 | Imp College Innovations Ltd | Compound |
KR20010069179A (ko) * | 1999-05-28 | 2001-07-23 | 박종상 | 유전자 전달용 양이온성 리피드 및 그 제조방법 |
FR2797188A1 (fr) * | 1999-08-04 | 2001-02-09 | Univ Paris Nord Laboratoire De | Composes lipidiques cationiques et leurs utilisation pour le transfert de substances d'interet therapeutique chargees negativement |
WO2001040254A1 (fr) * | 1999-12-02 | 2001-06-07 | Tomohiko Ohwada | Reactifs pour transfert de genes |
WO2002048380A2 (en) * | 2000-12-12 | 2002-06-20 | Mitsubishi Chemical Corporation | Glycosilated cationic lipids for liposomes used in drug delivery |
EP1669366A1 (en) * | 2000-12-12 | 2006-06-14 | Mitsubishi Chemical Corporation | Lipids comprising an aminoxy group |
DE10109898A1 (de) | 2001-02-21 | 2002-09-05 | Novosom Gmbh | Lipide mit veränderlicher Ladung |
US7906122B2 (en) | 2003-06-18 | 2011-03-15 | Yissum Research Development Company Of The Hebrew University Of Jersusalem | Sphingoid polyalkylamine conjugates for Hepatitis B virus vaccination |
AU2004246905B2 (en) | 2003-06-18 | 2010-01-21 | Biolab Ltd. | Sphingoid polyalkylamine conjugates for vaccination |
GB0418172D0 (en) * | 2004-08-13 | 2004-09-15 | Ic Vec Ltd | Vector |
US20060211004A1 (en) | 2005-02-15 | 2006-09-21 | Ilsley Diane D | Methods and compositions for determining non-specific cytotoxicity of a transfection agent |
WO2006126208A2 (en) | 2005-05-26 | 2006-11-30 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Compositions and methods using same for delivering agents into a target organ protected by a blood barrier |
CA2628300C (en) | 2005-11-02 | 2018-04-17 | Protiva Biotherapeutics, Inc. | Modified sirna molecules and uses thereof |
JP2010513354A (ja) * | 2006-12-19 | 2010-04-30 | ノヴォソム アクチェンゲゼルシャフト | トランスフェクションエンハンサー要素を含む脂質および脂質集合体 |
US9006191B2 (en) | 2007-12-27 | 2015-04-14 | Protiva Biotherapeutics, Inc. | Silencing of polo-like kinase expression using interfering RNA |
EP2770057A1 (en) | 2008-04-15 | 2014-08-27 | Protiva Biotherapeutics Inc. | Silencing of CSN5 gene expression using interfering RNA |
GB0908963D0 (en) | 2009-05-22 | 2009-07-01 | Imuthes Ltd | Compositions |
AU2011268146A1 (en) | 2010-06-17 | 2013-01-10 | Actogenix Nv | Compositions and methods for treating inflammatory conditions |
CA2826594C (en) | 2011-02-03 | 2019-09-17 | The Government Of The U.S.A., As Represented By The Secretary, Department Of Health & Human Services | Multivalent vaccines for rabies virus and filoviruses |
US20150240238A1 (en) | 2011-11-17 | 2015-08-27 | The Regents Of The University Of California | Therapeutic rna switches compositions and methods of use |
US9035039B2 (en) | 2011-12-22 | 2015-05-19 | Protiva Biotherapeutics, Inc. | Compositions and methods for silencing SMAD4 |
CZ303963B6 (cs) * | 2012-01-13 | 2013-07-17 | Ústav organické chemie a biochemie Akademie ved CR, v.v.i. | Lipopolyaminy sperminového typu pro konstrukci liposomálních transfekcních systému |
BR112014021065A8 (pt) | 2012-02-21 | 2018-04-24 | Centre Nat Rech Scient | receptores tam como cofatores de entrada do vírus |
MX2014010016A (es) | 2012-02-21 | 2015-06-05 | Inst Nat Sante Rech Med | Receptores de mucina de inmunoglobulina de celula t (tim) como co-factores de entrada del virus. |
AU2013295242C1 (en) | 2012-07-27 | 2018-08-09 | Institut National De La Sante Et De La Recherche Medicale | CD147 as receptor for pilus-mediated adhesion of meningococci to vascular endothelia |
CN104884065B (zh) | 2012-09-21 | 2019-01-01 | 强烈治疗剂公司 | 治疗癌症的方法 |
SG11201702662UA (en) | 2014-10-02 | 2017-04-27 | Protiva Biotherapeutics Inc | Compositions and methods for silencing hepatitis b virus gene expression |
US10314839B2 (en) | 2014-10-20 | 2019-06-11 | Elysium Therapeutics, Inc. | Diversion-resistant opioid formulations |
CN209264567U (zh) | 2015-04-09 | 2019-08-16 | 必康达 | 使用荧光纳米金刚石的成像系统 |
WO2016197132A1 (en) | 2015-06-04 | 2016-12-08 | Protiva Biotherapeutics Inc. | Treating hepatitis b virus infection using crispr |
WO2017019891A2 (en) | 2015-07-29 | 2017-02-02 | Protiva Biotherapeutics, Inc. | Compositions and methods for silencing hepatitis b virus gene expression |
US20170360815A1 (en) | 2016-02-25 | 2017-12-21 | Applied Biological Laboratories, Inc. | Compositions and methods for protecting against airborne pathogens and irritants |
JP7071933B2 (ja) | 2016-02-25 | 2022-05-19 | アプライド バイオロジカル ラボラトリーズ インコーポレイテッド | 浮遊病原体および刺激物に対して防御するための組成物および方法 |
EP4104854A3 (en) | 2016-04-04 | 2023-03-08 | The United States of America as represented by the Secretary of the Department of Health and Human Services | Multivalent vaccines for rabies virus and coronaviruses |
EP3713603A1 (en) | 2017-11-23 | 2020-09-30 | Institut National de la Sante et de la Recherche Medicale (INSERM) | New method for treating dengue virus infection |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2861262B2 (ja) * | 1990-05-23 | 1999-02-24 | 東ソー株式会社 | アミノ酸誘導体及びその製造法 |
US5283185A (en) * | 1991-08-28 | 1994-02-01 | University Of Tennessee Research Corporation | Method for delivering nucleic acids into cells |
US5972600A (en) * | 1992-04-03 | 1999-10-26 | The Regents Of The University Of California | Separation of active complexes |
ES2123133T3 (es) * | 1993-03-10 | 1999-01-01 | Magainin Pharma | Derivados esteroidianos, composiciones farmaceuticas que contienen estos derivados esteroidianos y utilizacion de estos ultimos como antibioticos o desinfectantes. |
US5777153A (en) * | 1994-07-08 | 1998-07-07 | Gilead Sciences, Inc. | Cationic lipids |
WO1996008270A2 (en) * | 1994-09-13 | 1996-03-21 | Magainin Pharmaceuticals Inc. | Method for inhibiting sexually transmitted diseases using magaining antimicrobials or squalamine compounds |
US5837533A (en) * | 1994-09-28 | 1998-11-17 | American Home Products Corporation | Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent |
US6071890A (en) * | 1994-12-09 | 2000-06-06 | Genzyme Corporation | Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy |
US5767099A (en) * | 1994-12-09 | 1998-06-16 | Genzyme Corporation | Cationic amphiphiles containing amino acid or dervatized amino acid groups for intracellular delivery of therapeutic molecules |
AU701106B2 (en) * | 1995-06-07 | 1999-01-21 | Promega Biosciences, Inc. | Novel carbamate-based cationic lipids |
CA2223921A1 (en) * | 1995-06-07 | 1996-12-19 | Francis C. Szoka, Jr. | Stabilization of polynucleotide complexes |
US5811406A (en) * | 1995-06-07 | 1998-09-22 | Regents Of The University Of California | Dry powder formulations of polynucleotide complexes |
-
1997
- 1997-05-23 JP JP54184097A patent/JP4340330B2/ja not_active Expired - Fee Related
- 1997-05-23 US US09/194,267 patent/US6756054B1/en not_active Expired - Fee Related
- 1997-05-23 AU AU29111/97A patent/AU2911197A/en not_active Abandoned
- 1997-05-23 EP EP97923255A patent/EP0918790B1/en not_active Expired - Lifetime
- 1997-05-23 DE DE69727384T patent/DE69727384T2/de not_active Expired - Lifetime
- 1997-05-23 WO PCT/GB1997/001426 patent/WO1997045442A1/en active IP Right Grant
-
2004
- 2004-02-02 US US10/770,294 patent/US20040156890A1/en not_active Abandoned
-
2007
- 2007-10-05 US US11/868,184 patent/US20080075763A1/en not_active Abandoned
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008509205A (ja) * | 2004-08-13 | 2008-03-27 | アイシー・ベック・リミテッド | ポリマー修飾siRNAリポソームを含むベクター |
JP2008520610A (ja) * | 2004-11-19 | 2008-06-19 | グラクソ グループ リミテッド | トランスフェクション剤としてのテトラアルキレンペンタミンのアミドおよびペプチド誘導体 |
JP2015530382A (ja) * | 2012-08-28 | 2015-10-15 | メディカル リサーチ カウンシル | ナノ粒子製剤 |
Also Published As
Publication number | Publication date |
---|---|
EP0918790B1 (en) | 2004-01-28 |
EP0918790A1 (en) | 1999-06-02 |
US20040156890A1 (en) | 2004-08-12 |
US20080075763A1 (en) | 2008-03-27 |
JP4340330B2 (ja) | 2009-10-07 |
WO1997045442A1 (en) | 1997-12-04 |
DE69727384D1 (de) | 2004-03-04 |
US6756054B1 (en) | 2004-06-29 |
AU2911197A (en) | 1998-01-05 |
DE69727384T2 (de) | 2004-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4340330B2 (ja) | トランスフェクション剤としてのポリカチオン性ステロール誘導体 | |
AU2004305111B2 (en) | Cell transfecting formulations of small interfering RNA, related compositions and methods of making and use | |
AU738083B2 (en) | Cationic amphiphile/ DNA complexes | |
JP4695075B2 (ja) | トランスフェクションで使用するためのスフィンゴ脂質ポリアルキルアミン抱合体 | |
JP3688278B2 (ja) | 自己構築ポリヌクレオチド送達システム | |
US7507859B2 (en) | Functional synthetic molecules and macromolecules for gene delivery | |
AU731503B2 (en) | Cationic amphiphile compositions for intracellular delivery of therapeutic molecules | |
WO1998002190A9 (en) | Cationic amphiphile/dna complexes | |
WO1996018372A2 (en) | Cationic amphiphiles and plasmids for intracellular delivery of therapeutic molecules | |
JP2000501383A (ja) | トランスフェクション剤としてのリポポリアミン及びその医薬的使用 | |
JP2000502061A (ja) | カチオン脂質複合体 | |
JP2001501975A (ja) | 亢進した細胞取り込みを有する結合ペプチド核酸 | |
WO1999002190A1 (en) | Organ-specific targeting of cationic amphiphile/retinoblastoma encoding dna complexes for gene therapy | |
EP1351972B1 (en) | Lipids comprising an aminoxy group | |
AU2002222128A1 (en) | Lipids comprising an aminoxy group | |
US20020188023A1 (en) | Compound | |
WO1998050416A1 (en) | Cationic amphiphiles containing multiple steroid lipophilic groups | |
EP1007003A1 (en) | Cationic amphiphile compositions for intracellular delivery of therapeutic molecules | |
JP4252461B2 (ja) | 治療分子の細胞内伝達のためのカチオン性両親媒質、その組成物、工程およびそれらの使用 | |
AU736143B2 (en) | Cationic amphiphile compositions for intracellular delivery of therapeutic molecules | |
AU716706C (en) | Cationic amphiphiles and plasmids for intracellular delivery of therapeutic molecules | |
EP1669366A1 (en) | Lipids comprising an aminoxy group |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040518 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080422 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20080718 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080901 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20080919 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20081027 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20081021 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20081216 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090313 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090427 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090415 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20090609 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20090706 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120710 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130710 Year of fee payment: 4 |
|
LAPS | Cancellation because of no payment of annual fees |